Summary
Chen and Mellman's 2017 Nature review synthesises current understanding of cancer immunology, proposing that tumour control depends on a dynamic equilibrium—the 'cancer–immune set point'—between anti-tumour immune responses and mechanisms of immune evasion. The paper discusses immune checkpoint pathways (PD-1, CTLA-4 and related molecules) as critical regulators of this set point, with implications for therapeutic intervention. This conceptual framework helped shape the rationale for checkpoint inhibitor development in clinical oncology.
UK applicability
Whilst this is a fundamental immunology paper rather than an agricultural or nutritional systems study, its findings underpin NHS treatment guidelines for checkpoint inhibitor therapies. The work is tangentially relevant to food systems research insofar as dietary and farming practices may modulate immune function and cancer risk; however, the paper makes no direct claims about food, nutrition or agriculture.
Key measures
Immune checkpoint expression, T-cell activation, tumour immune infiltration, immune tolerance mechanisms
Outcomes reported
The paper examines the immunological principles governing cancer immunity and proposes a conceptual framework for understanding the 'cancer–immune set point'—the balance between anti-tumour immunity and tumour-promoting factors. It synthesises evidence on immune checkpoint mechanisms and their role in controlling malignant transformation.
Topic tags
Dig deeper with Pulse AI.
Pulse AI has read the whole catalogue. Ask about this record, its theme, or how the findings apply to UK farming and policy — every answer cites the underlying studies.